1型糖尿病患者的肝脏脂肪含量没有增加:马斯特里赫特研究
Nefeli M Dimitropoulou1,2, Magdalena Beran3,4, Simone J P M Eussen4,5,6
1Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands. nefeli.dimitropoulou@maastrichtuniversity.nl.
Diabetologia
|November 6, 2025
概括
与2型糖尿病患者相比,1型糖尿病患者的肝脂肪含量较低,与没有糖尿病的人相似. 这种差异与胰岛素敏感性和治疗有关,而不是肥胖或饮食.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肥胖和饮食不良导致2型糖尿病的高肝脂肪.
- 1型糖尿病患者越来越多地出现肥胖和不良饮食习惯.
- 在1型糖尿病中,肝脏脂肪积累的风险尚不清楚.
研究的目的:
- 为了比较1型糖尿病,2型糖尿病和没有糖尿病的个体的肝脏脂肪含量.
- 为了研究糖尿病类型和肝脏肥胖症之间的关系.
主要方法:
- 马斯特里赫特研究,一个基于人口的队列,提供了数据.
- 磁共振成像 (MRI) 量化了肝脏脂肪含量.
- 多个线性回归分析比较了肝脂肪,调整了诸如BMI,心血管疾病风险因素,生活方式,饮食,胰岛素使用和估计的葡萄糖处置率 (eGDR) 等混因素.
主要成果:
- 肝脏脂肪含量在1型糖尿病 (2.1%) 中低于2型糖尿病 (4.9%) (p=0.001).
- 1型糖尿病患者的肝脂肪与没有糖尿病的患者 (2.6%) 相似.
- 1型和2型糖尿病之间的差异独立于肥胖和饮食,但在调整为eGDR和胰岛素治疗后减弱.
结论:
- 1型糖尿病患者的肝脂肪与非糖尿病患者相比,与2型糖尿病患者相比较少.
- 这种差异独立于肥胖和饮食因素.
- 胰岛素敏感性和治疗部分解释了肝脏脂肪含量观察到的差异.
更多相关视频
相关概念视频
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


